Figure 1.
Probability of disease-free (DFS) and overall survival (OS) for standard-risk adult acute lymphoblastic leukemia patients. Patients are further stratified into low-risk (LR), intermediate-risk (IR) and high-risk (HR) as determined by extent of minimal residual disease.
Reprinted with permission from
Brüggemann M, et al. Blood2006;107:1116–1123.